Quince Therapeutics, Inc.QNCXNASDAQ
LOADING
|||
R&D Expense Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
96.78%
↑ 169% above average
Average (7y)
36.03%
Historical baseline
Range
High:199.59%
Low:-62.48%
Volatility
727.4%
High variability
| Period | Value |
|---|---|
| 2024 | 96.78% |
| 2023 | -62.48% |
| 2022 | -58.59% |
| 2021 | -0.84% |
| 2020 | 102.91% |
| 2019 | 199.59% |
| 2018 | 10.84% |
| 2017 | 0.00% |